Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Daily News

Out-of-Hospital Cardiac Arrest Protocol With Cooling, Angiography Gets ‘Extraordinary’ Results

Caitlin E. Cox

September 19, 2018

News Daily News

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

Shelley Wood

July 19, 2018

Presentation CDM 2017

Cardiopulmonary Arrest: Therapeutic Hypothermia and Compression Only CPR

Presenter: Jason Bartos

October 05, 2017

News Daily News

Smartphone App Mobilizes Members of the Public to Be Cardiac Arrest First Responders

Todd Neale

June 21, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Daily News

Time to Centralize Care for Out-of-Hospital Cardiac Arrest?

Alison Palkhivala

April 10, 2017

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

仅限罪犯血管的PCI可能对患有多血管病变、心源性休克的MI患者更好

September 11, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

Presentation TCT 2013

Is There a Role For ECMO Plus Immediate PCI in CPR Nonresponders?

Presenter: Eisuke Kagawa

October 31, 2013

News Daily News

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Caitlin E. Cox

August 24, 2012

News Daily News

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

April 27, 2011

News Daily News

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Jason Kahn

March 31, 2011

Advertisement

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Out-of-Hospital Cardiac Arrest Protocol With Cooling, Angiography Gets ‘Extraordinary’ Results

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

Cardiopulmonary Arrest: Therapeutic Hypothermia and Compression Only CPR

Smartphone App Mobilizes Members of the Public to Be Cardiac Arrest First Responders

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Time to Centralize Care for Out-of-Hospital Cardiac Arrest?

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

仅限罪犯血管的PCI可能对患有多血管病变、心源性休克的MI患者更好

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Is There a Role For ECMO Plus Immediate PCI in CPR Nonresponders?

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content